Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Intractable Hemophagocytic Syndrome Associated with Systemic Lupus Erythematosus Resistant to Corticosteroids and Intravenous Cyclophosphamide That Was Successfully Treated with Cyclosporine A
Hirofumi TokoHiroto TsuboiNaoto UmedaFumika HondaAyako OhyamaHidenori TakahashiSaori AbeMasahiro YokosawaHiromitsu AsashimaShinya HagiwaraTomoya HirotaYuya KondoIsao MatsumotoTakayuki Sumida
著者情報
ジャーナル オープンアクセス

2018 年 57 巻 18 号 p. 2747-2752

詳細
抄録

Hemophagocytic syndrome (HPS) associated with systemic lupus erythematosus (SLE), dubbed acute lupus hemophagocytic syndrome (ALHS), is an intractable complication of SLE. A 24-year-old man who had been diagnosed with SLE three months previously, presented with fever, rash, hallucination, and pancytopenia accompanied with hyperferritinemia and bone marrow hemophagocytosis. He was diagnosed with ALHS and neuropsychiatric (NP)-SLE. Although 4 courses of methylprednisolone pulse therapy and 1 course of intravenous cyclophosphamide (IVCY) improved his NP-SLE, his ALHS did not respond. However, the addition of cyclosporine A (CsA) led to a rapid remission from ALHS. This suggests the usefulness of CsA in the treatment of intractable, corticosteroid- and IVCY-resistant ALHS.

著者関連情報
© 2018 by The Japanese Society of Internal Medicine
前の記事 次の記事
feedback
Top